AstraZeneca names Zook to head North America

Share this article:
AstraZeneca named Tony Zook executive vice president for North America, succeeding David Brennan, who was named chief executive of the company in July.
 Zook is slated to assume his duties Jan. 1, 2006, as Brennan takes over the reigns from the retiring Sir Tom McKillop, whose leadership began following the 1999 merger of Astra AB and Zeneca.
Currently, Zook serves as AstraZeneca's senior vice president, U.S. commercial operations. 
Share this article:

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...